BioText-SeqFormer: Integrating biomedical semantic representations and protein sequence embeddings for TCR-peptide interaction prediction.
BioText-SeqFormer aims to crack one of the toughest puzzles in immunology: predicting which T cell receptors (TCRs) will bind to which peptides. This is a big deal for anyone studying cancer immunotherapy, infectious diseases, or vaccine design. The old way—lab screening—works, but it’s slow and expensive. Machine learning helps, but most models just look at amino acid sequences and ignore the deeper biomedical context. That’s where BioText-SeqFormer steps in.
Comput Biol Chem
by Wang Z, Chen Z, Li D
“BioText-SeqFormer: Integrating biomedical semantic representations and protein sequence embeddings for TCR-peptide interaction prediction. Wang Z(1), Chen Z(2), Li D(3). Author information: (1)College of Information Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China. (2)PetroChina Petrochemical Research Institute, Beijing, 102206, China. (3)College of Information Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China. Electronic address: lidz@mail.buct.edu.cn. The interaction between T cell receptors (TCRs) and antigenic peptides is central to adaptive immune recognition and is important for cancer immunotherapy, infectious disease research, and vaccine design. Although experimental screening methods are reliable, they are often costly and time-consuming, making it difficult to explore the vast combinatorial space of TCR-peptide pairs. Machine learning and deep learning methods provide efficient alternatives for TCR-peptide binding prediction, but most existing models mainly rely on amino acid sequence representations and make limited use of biomedical semantic information related to immune recognition. This limitation may restrict their ability to characterize complex binding patterns. To address this issue, we propose BioText-SeqFormer, a TCR-peptide interaction prediction framework that integrates task-adapted biomedical language semantic representations with protein sequence embeddings. The model constructs task-related biomedical textual representations and combines them with sequence embeddings extracted by a protein language model. Cross-modal Transformer encoding and the Complementary Fusion-Gating Aggregation (CFGA) module are used to model interactions among semantic, peptide, and TCR sequence features. Experiments on two public datasets, IEDB and McPAS-TCR, show that BioText-SeqFormer achieves stable and competitive predictive performance. Additional Top-k positive predictive value analysis, high-frequency peptide and TCR analysis, 9-mer peptide position-amino acid association analysis, and VDJdb-COVID transfer experiments further demonstrate its candidate screening ability, interpretability, and potential in few-shot transfer scenarios. Overall, this study provides a multimodal strategy for TCR-peptide interaction prediction by integrating language semantics and protein sequence representations. Copyright © 2026. Published by Elsevier Ltd. Conflict of interest statement: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.”
The researchers behind BioText-SeqFormer built a framework that blends two worlds. It combines protein sequence embeddings (the usual suspects in peptide prediction) with specialized biomedical language semantics. In simple terms: the model doesn’t just “see” the peptide and TCR sequences. It “reads” the relevant biomedical literature and integrates that semantic knowledge, making its predictions smarter and more context-aware.
Key features:
Uses cross-modal Transformers to bring together semantic data and protein sequences.
Deploys a fusion-gating module to capture complex interaction patterns that older models miss.
Stands up to the test on big public datasets like IEDB and McPAS-TCR, holding its own against the competition.
Researchers also ran deeper analyses—like which peptide and TCR combos show up most often, and how amino acids line up at each position in 9-mer peptides. The model’s performance held up even in “few-shot” scenarios, making it promising for rare or new TCR-peptide pairs. That’s a win for rapid candidate screening and more interpretable results.
Takeaway: BioText-SeqFormer signals a new chapter for TCR-peptide prediction. By mixing sequence data with biomedical language, it opens up more possibilities for peptide research and immune recognition. For anyone obsessed with decoding peptide interactions, this is a tool worth watching.
Related Reading
[Application of cell-penetrating peptides in tumor therapy].
News · SmallReverse Micelles: The Gateway for Oral (Poly)Peptide Delivery.
News · Front PharmacolTirzepatide versus other glucose-lowering therapies and risk of COPD exacerbations in patients with comorbid type 2 diabetes: a retrospective cohort study.
For Research Use Only
All content published on Pushing Peptides is intended for educational and informational purposes only. The information provided is not intended as medical advice, diagnosis, or treatment. Peptides discussed in this article are research compounds and are not approved for human therapeutic use by the FDA or any other regulatory agency. All studies referenced involve animal models or in vitro research unless otherwise stated. Consult a qualified healthcare professional before making any decisions related to your health. Pushing Peptides does not sell peptides — we are a vendor directory and educational resource.